Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies, sold ADPT on Jun 26, 2026
Data as of Oct 16
▼ SELL$232K11,034 shares at $21.00Sharon Benzeno Chief Commercial Ofc Imm MedADPT Adaptive Biotechnologies Corp
- Traded
- Jun 26, 2026
- Disclosed
- Jun 30, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ADPT since disclosure
+12.0%
after the sale
Similar stocks (XLV) since disclosure
+11.4%
XLV — its sector index fund
Change in closing price from Jun 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLSharon Benzeno Chief Commercial Ofc Imm MedADPT Adaptive Biotechnologies Corp$3.3Mdisclosed Jun 30 · filed 1 day after the trade